Hottest Stocks (Over $10)	Hottest Stocks ($2-$10)	Biggest Losers (Over $10)	Biggest Losers ($2-$10)	Hottest Industries	Hottest Sectors	EPS / Sales Surprises
Enter Ticker Symbol:   Ticker Lookup Company Quote Company Profile Research Summary EPS Consensus Perspective Insider Transactions Price Performance

Enter any portion of the company’s name to find its corresponding ticker symbol:

Search for :

Zacks Company Profile for Aclarion, Inc. (ACON : NSDQ)

• Company Description    Aclarion Inc. is a healthcare technology company which leverages Magnetic Resonance Spectroscopy and a proprietary biomarker to optimize clinical treatments. The Company is also researching the application of AI and machine learning platforms to analyze both the raw spectroscopy data and the post-processed signal to evaluate whether AI platforms. Aclarion Inc. is based in SAN MATEO, CA. Number of Employees: 11

• Price / Volume Information    Yesterday's Closing Price: $3.21 Daily Weekly Monthly 20 Day Moving Average: 45,684 shares Shares Outstanding: 2.46 (millions) Market Capitalization: $7.90 (millions) Beta: 1.18 52 Week High: $12.03 52 Week Low: $2.34 Short Interest Ratio:   % Price Change % Price Change Relative to S&P 500 4 Week -1.53% -6.34% 12 Week 19.78% 10.73% Year To Date -30.22% -34.84%

• Address & Contact Information Street Address Phone / Fax Email Address Web URL 8181 Arista Place Suite 100 - Broomfield,CO 80021 USA ph: 833-275-2266 fax: - None http://www.aclarion.com

• General Corporate Information    Officers Brent Ness - President; Chief Executive Officer and Director Jeffrey Thramann - Executive Chairman Gregory A. Gould - Chief Financial Officer Stephen Deitsch - Director David Neal - Director Peer Information Aclarion, Inc. (CHCR) Aclarion, Inc. (ESRX) Aclarion, Inc. (MYDP) Aclarion, Inc. (COR) Aclarion, Inc. (GBCS) Aclarion, Inc. (LAXAF) Industry / Sector / Ticker Info Analyst Coverage: No Industry Group: Medical Services Sector: Medical CUSIP: 655187409 SIC: 8071 Fiscal Year Fiscal Year End: December Last Reported Quarter: 03/01/26 Next Expected EPS Date: 08/13/26 Share - Related Items Shares Outstanding: 2.46 Most Recent Split Date: 3.00 (0.04:1) Beta: 1.18 Market Capitalization: $7.90 (millions)

• EPS Information     • Dividend Information Analyst Coverage: No Dividend Yield: 0.00% Current Fiscal Quarter EPS Consensus Estimate: $-0.95 Indicated Annual Dividend: $0.00 Current Fiscal Year EPS Consensus Estimate: $-4.37 Payout Ratio: Number of Estimates in the Fiscal Year Consensus: 1.00 Change In Payout Ratio: Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00 Next EPS Report Date: 08/13/26

• Fundamental Ratios P/E Current FY Estimate: - Trailing 12 Months: - PEG Ratio: - Price Ratios Price/Book: 0.40 Price/Cash Flow: - Price / Sales: 101.33 EPS Growth vs. Year Ago Period: 85.62% vs. Previous Quarter: 33.33% Sales Growth vs. Year Ago Period: 10.53% vs. Previous Quarter: 10.53% ROE 03/31/26 - -54.41 12/31/25 - -52.31 09/30/25 - -67.53 ROA 03/31/26 - -51.71 12/31/25 - -49.79 09/30/25 - -63.01 Current Ratio 03/31/26 - 19.65 12/31/25 - 14.81 09/30/25 - 17.01 Quick Ratio 03/31/26 - 19.65 12/31/25 - 14.81 09/30/25 - 17.01 Operating Margin 03/31/26 - -10,320.51 12/31/25 - -9,517.11 09/30/25 - -10,908.50 Net Margin 03/31/26 - -10,320.51 12/31/25 - -9,517.11 09/30/25 - -10,908.50 Pre-Tax Margin 03/31/26 - -10,321.80 12/31/25 - -9,552.36 09/30/25 - -10,908.50 Book Value 03/31/26 - 7.98 12/31/25 - 15.02 09/30/25 - 21.47 Inventory Turnover 03/31/26 - - 12/31/25 - - 09/30/25 - - Debt-to-Equity 03/31/26 - 0.00 12/31/25 - 0.00 09/30/25 - 0.00 Debt-to-Capital 03/31/26 - 0.00 12/31/25 - 0.00 09/30/25 - 0.00

Powered by Zacks Investment Research ©